Exchange: NYSEMkt·Updated 07:59 PM EDT
News
all
press releases
Ur Energy (URG) Reports Q2 Loss, Tops Revenue Estimates
Ur Energy (URG) delivered earnings and revenue surprises of -33.33% and +7.00%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Cameco Gains 7% Despite Q2 Earnings Miss: How to Play the Stock?
CCJ shares jump 7% despite a Q2 earnings miss, as investors weighed Westinghouse IPO plans, resilient guidance and a stretched valuation.
Zacks
LEU's Q2 Earnings Beat, Revenues up Y/Y on Strong Uranium Sales
Centrus Energy beats Q2 earnings and revenue estimates, but higher administrative and technology costs sharply compress margins.
Zacks
CCJ Overcomes Disruptions at McArthur River: Can It Deliver 2026 Goals?
Cameco restores full production at McArthur River and Key Lake after flood-related logistics disruptions, maintaining confidence in 2026 uranium output targets.
Zacks
UEC Gears Up to Report Q3 Earnings: What's in Store for the Stock?
Uranium Energy heads into Q3 FY2026 with expected uranium sales gains, but higher operating and exploration costs may widen losses.
Zacks
Can Energy Fuels Maintain Its Strong Uranium Growth in 2026?
UUUU mines ~425K lbs of contained uranium across mines, signaling strong output vs. 115K lbs year ago and rising momentum into 2026.
Zacks
Cameco Faces Production Disruptions: Can Output Targets Still Hold?
CCJ maintains 2026 production outlook despite Saskatchewan flooding disrupting transport routes to McArthur River and Key Lake operations.
Zacks
Can Denison Mines Advance Phoenix With Uranium-Backed Funding Plan?
DNN advances Phoenix uranium project with approvals, early construction and financing moves, aiming for the first Canadian ISR mine and near-term production.
Zacks
DNN Stock Trades at Premium Value: Should You Buy, Hold or Sell?
Denison Mines' premium valuation is backed by Phoenix ISR progress, rising uranium output and a strong balance sheet supporting long-term growth.
Zacks
Cameco Posts Q1 Earning Beat: A Compelling Reason to Buy the Stock?
CCJ beat Q1 estimates as uranium sales and EBITDA surged, but lower 2026 revenue guidance and a premium valuation may temper upside.
Zacks

Advertisement|Remove ads.